MS Ireland warmly welcomes the news that VHI has now included Lemtrada (Alemtuzumab) in the specified drug section of the Schedule of Benefits for Private Hospital Service, for admissions on or after 1st June 2016.
This means- VHI Insurance will provide reimbursement for Lemtrada subject to the rules, terms and conditions of VHI membership.